OBJECTIVE: To compare fertilization, cleavage, and pregnancy outcome using pentoxifylline and a hypoosmotic swelling (HOS) test to select viable spermatozoa from testicular biopsy specimens. DESIGN: Open, comparative, prospective study. SETTING: G.S. Medical College and Fertility clinic, Mumbai, India. PATIENT(S): A total of 50 couples enrolled for infertility treatment having a male factor indication of nonobstructive azoospermia. INTERVENTION(S): Assessment of viable spermatozoa using pentoxifylline and using an HOS test from a population of nonmotile spermatozoa obtained from testicular biopsies. MAIN OUTCOME MEASURE(S): Comparison of fertilization, cleavage, and clinical pregnancy rates using viable sperms recovered using pentoxifylline and an HOS test. RESULT(S): Viable spermatozoa were obtained in both the study groups. Significantly higher fertilization rates (pentoxifylline 62.05% vs. HOS 41.07%) and clinical pregnancy rates (pentoxifylline 32% vs. HOS 16%) were observed. There was no significant difference in cleavage rates among both groups. CONCLUSION(S): We found that obtaining viable spermatozoa using pentoxifylline was more effective in terms of fertilization and pregnancies than obtaining it through an HOS test.
OBJECTIVE: To compare fertilization, cleavage, and pregnancy outcome using pentoxifylline and a hypoosmotic swelling (HOS) test to select viable spermatozoa from testicular biopsy specimens. DESIGN: Open, comparative, prospective study. SETTING: G.S. Medical College and Fertility clinic, Mumbai, India. PATIENT(S): A total of 50 couples enrolled for infertility treatment having a male factor indication of nonobstructive azoospermia. INTERVENTION(S): Assessment of viable spermatozoa using pentoxifylline and using an HOS test from a population of nonmotile spermatozoa obtained from testicular biopsies. MAIN OUTCOME MEASURE(S): Comparison of fertilization, cleavage, and clinical pregnancy rates using viable sperms recovered using pentoxifylline and an HOS test. RESULT(S): Viable spermatozoa were obtained in both the study groups. Significantly higher fertilization rates (pentoxifylline 62.05% vs. HOS 41.07%) and clinical pregnancy rates (pentoxifylline 32% vs. HOS 16%) were observed. There was no significant difference in cleavage rates among both groups. CONCLUSION(S): We found that obtaining viable spermatozoa using pentoxifylline was more effective in terms of fertilization and pregnancies than obtaining it through an HOS test.
Authors: Rafael Favero Ambar; Marcello M Gava; Milton Ghirelli-Filho; Ivan H Yoshida; Thais Serzedello De Paula; Sidney Glina Journal: Arab J Urol Date: 2021-07-22